Biglycan
Biglycan (BGN) is a secreted extracellular matrix proteoglycan of the small leucine-rich proteoglycan (SLRP) family, and it may be involved in collagen fibre assembly. It is also known as DSPG1 or SLRP1A. Browse Assay Genie's current range of Biglycan research reagents below, or read on for the biology behind the target.
Biglycan is a proteoglycan that is secreted into the extracellular space and deposited in the extracellular matrix. UniProt annotates it as possibly involved in collagen fibre assembly, and the NCBI Gene summary extends this to collagen fibril assembly in multiple tissues. The same summary describes roles for the mature protein in bone growth and in muscle development and regeneration, and suggests it may also regulate inflammation and innate immunity.
The BGN gene encodes a preproprotein that is proteolytically processed to give the mature biglycan protein. Biglycan belongs to the small leucine-rich proteoglycan (SLRP) family and to the class I subfamily, and HGNC places it in the group of small leucine rich proteoglycans. The human gene lies at Xq28, and the mouse and rat orthologs are both named Bgn, so the protein can be studied in common rodent models.
Biglycan and the related gene decorin are thought to have arisen through a gene duplication. This shared origin is relevant when comparing the two proteoglycans in matrix biology. In human disease research, the encoded protein may contribute to atherosclerosis and to aortic valve stenosis. Alternative names found in the literature include DSPG1 and SLRP1A, so searches for biglycan work across all three terms.
Biglycan may be involved in collagen fibre assembly, making it a candidate for studies of how collagen fibrils form in multiple tissues.
The mature protein plays a role in bone growth and in muscle development and regeneration.
Biglycan may regulate inflammation and innate immunity, which makes it of interest in immune signalling research.
The protein may contribute to atherosclerosis and aortic valve stenosis in human patients, supporting its study in vascular and valve disease.
Biglycan is a secreted extracellular matrix proteoglycan that may be involved in collagen fibre assembly. According to the NCBI Gene summary, the mature protein plays a role in bone growth, muscle development and regeneration, and collagen fibril assembly, and may regulate inflammation and innate immunity.
Biglycan is encoded by the BGN gene, and it is also known as DSPG1 and SLRP1A. It is synthesised as a preproprotein that is proteolytically processed into the mature protein. HGNC lists it in the small leucine rich proteoglycans gene group.
The encoded protein may contribute to atherosclerosis and aortic valve stenosis in human patients. Biglycan has mouse and rat orthologs, both named Bgn, and it shares a gene duplication origin with decorin. Check the datasheet of any product for its validated reactivity.
Other small leucine-rich proteoglycans, collagen and extracellular matrix targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P21810; product specifications from Assay Genie datasheets.